Daewoong Famciclovir Tablet 750mg

Adult dosage

1. Treatment of herpes zoster Adults: Administer famciclovir 250 mg orally per dose 3 times daily for 7 days. It is preferable to start treatment as soon as symptoms appear after infection. 2. Treatment of an initial episode of genital herpes Adults: Administer this drug 250 mg orally per dose 3 times daily for 5 days. It is preferable to start treatment as soon as symptoms appear after infection. 3. Treatment of acute recurrent genital herpes Adults: Administer this drug 125 mg orally per dose 2 times daily for 5 days. It is preferable to start treatment during the prodromal period or as soon as symptoms appear after infection. 4. Suppression of recurrent genital herpes Adults: Administer this drug 250 mg orally per dose 2 times daily. Temporarily discontinue treatment periodically every 6～12 months to assess any change in the natural course of the disease. 5. Patients with renal impairment 1) Treatment of herpes zoster and an initial episode of genital herpes: Creatinine clearance (mL/min/1.73㎡) 30～59: 250 mg per dose 2 times daily Creatinine clearance (mL/min/1.73㎡) 10～29: 250 mg per dose once daily 2) Treatment of acute recurrent genital herpes: Creatinine clearance (mL/min/1.73㎡) 30～59: 125 mg per dose 2 times daily Creatinine clearance (mL/min/1.73㎡) 10～29: 125 mg per dose once daily 3) Suppression of recurrent genital herpes: Creatinine clearance (mL/min/1.73㎡) 30～59: 250 mg per dose 2 times daily Creatinine clearance (mL/min/1.73㎡) 10～29: 125 mg per dose 2 times daily 4) If only serum creatinine is known, creatinine clearance may be calculated using the following equations: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 5) Patients with renal impairment undergoing hemodialysis For patients undergoing hemodialysis, administration every 48 hours is preferable, taking the interval between dialysis sessions into consideration. A 4-hour hemodialysis session reduces the plasma concentration of this drug by approximately 75%; therefore, administer this drug immediately after dialysis. The recommended dose is 250mg for patients with herpes zoster and 125mg for patients with genital herpes. 6. Patients with hepatic impairment: No dose adjustment is required in patients with chronic compensated liver disease. There is insufficient treatment experience in patients with overt chronic decompensated liver disease; therefore, a clear recommended dose has not been established.

This medicine should not be used in patients who are allergic to this medicine or its main ingredients. This medicine contains lactose, so it should not be taken by patients with genetic disorders causing lactose intolerance. Caution is needed when using this medication in patients with poor kidney function. After taking this medicine, symptoms such as headaches or nausea may occur, but most are mild to moderate in severity. Since blood cell counts may decrease, consult a physician if any unusual symptoms appear. Symptoms such as dizziness, drowsiness, and confusion may occur, so caution is needed while driving or operating machinery. Liver dysfunction, skin rash, and itching have been reported, so if symptoms are severe, inform medical personnel immediately. In patients with reduced kidney function, acute renal failure may rarely occur, so caution is advised. This medicine does not cure genital herpes, and it is recommended to avoid sexual contact when symptoms are present. There may be interactions with other medications, so inform your healthcare provider of any medications you are currently taking. Women who are pregnant or may become pregnant, as well as breastfeeding women, should carefully consider the benefits and risks of using this medication. Children under 18 years old should avoid use as safety and efficacy have not been confirmed. Elderly patients may require dosage adjustments based on their kidney function. In case of overdose, seek medical care immediately for appropriate treatment, and blood dialysis can decrease the drug concentration. This medicine should be stored in a cool and dry place and kept out of reach of children. Transferring to another container may cause accidents or degradation of the medication's quality, so caution is advised.

headache

This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also important to store it in a cool and dry place, specifically below 30 degrees Celsius.

Appearance

White rectangular film-coated tablet

Package unit

Company packaging unit